发布求助
文献互助 智能选刊 最新文献

Future Science OA最新文献

筛选
英文 中文
Relationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis. 使用 SGLT2 抑制剂与特定癌症类型之间的关系：系统回顾和荟萃分析。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-09-30 DOI: 10.1080/20565623.2024.2400797
Muhammad Ishtiaq Obaid, Mohammad Saiem Shahzad, Fakhar Latif, Muhammad Hamza Khan, Moeez Akram, Syed Asad Mehdi Rizvi, Rana Muhammad Umer Nasrullah, Dayab Asad, Muhammad Adil Obaid
{"title":"Relationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis.","authors":"Muhammad Ishtiaq Obaid, Mohammad Saiem Shahzad, Fakhar Latif, Muhammad Hamza Khan, Moeez Akram, Syed Asad Mehdi Rizvi, Rana Muhammad Umer Nasrullah, Dayab Asad, Muhammad Adil Obaid","doi":"10.1080/20565623.2024.2400797","DOIUrl":"10.1080/20565623.2024.2400797","url":null,"abstract":"<p><p><b>Aim:</b> The study aimed to explore the incidence of cancer as an adverse event to SGLT2 inhibitors (SGLT2i) use in Type 2 diabetes.<b>Materials & methods:</b> The study followed PRISMA guidelines to pool RCTs conforming the inclusion criteria. Random effects model was used to pool risk ratios.<b>Results & conclusion:</b> After reviewing 19 studies, the analysis suggested a possible increased risk of reproductive, breast, thyroid, hematologic/lymphatic, urinary, skin and skeletal cancers with SGLT2i use. Conversely, lower incidences of respiratory and cardiovascular cancers were noted. However, these associations lacked statistical significance. Caution is advised in using SGLT2i due to potential cancer risks, especially in diabetic patients prone to cancer. More RCTs are essential due to limited research in this area.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2400797"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local recurrences for mixed germ cell tumors without scrotal violation, is metastatic disease around the corner? A case report. 无阴囊侵犯的混合生殖细胞瘤局部复发，转移性疾病指日可待？病例报告。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-11-14 DOI: 10.1080/20565623.2024.2420543
Georges Abi Tayeh, Constance Michel, Xavier Durand
{"title":"Local recurrences for mixed germ cell tumors without scrotal violation, is metastatic disease around the corner? A case report.","authors":"Georges Abi Tayeh, Constance Michel, Xavier Durand","doi":"10.1080/20565623.2024.2420543","DOIUrl":"10.1080/20565623.2024.2420543","url":null,"abstract":"<p><p>We hereby report the case of a 40-year-old male, who initially underwent a left inguinal orchiectomy for a stage Is mixed germ cell tumor achieving an R0 status. His follow-up is mainly noticeable for many recurrences affecting exclusively the inguinal and suprapubic soft tissues. The recurrences occurred early, and almost always contained immature tissue upon pathologic reading, which has never been described in the medical literature before.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2420543"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572067/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the crisis: cocaine abuse's deadly connection to heart disease in Pakistan. 揭开危机的面纱：巴基斯坦可卡因滥用与心脏病的致命联系。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-11-14 DOI: 10.1080/20565623.2024.2419331
Jawad Ghias Shaikh, Ahmed Asad Raza, Muhammad Abdul Qadeer
{"title":"Unveiling the crisis: cocaine abuse's deadly connection to heart disease in Pakistan.","authors":"Jawad Ghias Shaikh, Ahmed Asad Raza, Muhammad Abdul Qadeer","doi":"10.1080/20565623.2024.2419331","DOIUrl":"10.1080/20565623.2024.2419331","url":null,"abstract":"","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2419331"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary actinomycosis complicating COVID-19 pneumonia in an immunocompetent patient: a case report. 免疫功能正常患者并发 COVID-19 肺炎的肺放线菌病：病例报告。
IF 2.4
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-11-21 DOI: 10.1080/20565623.2024.2411931
Narjes Abid, Manel Loukil, Ella Nemsi, Abir Chaabane, Siwar Sbaihi, Nada Gader, Khaoula Hemissi, Hedia Ghrairi
{"title":"Pulmonary actinomycosis complicating COVID-19 pneumonia in an immunocompetent patient: a case report.","authors":"Narjes Abid, Manel Loukil, Ella Nemsi, Abir Chaabane, Siwar Sbaihi, Nada Gader, Khaoula Hemissi, Hedia Ghrairi","doi":"10.1080/20565623.2024.2411931","DOIUrl":"10.1080/20565623.2024.2411931","url":null,"abstract":"<p><p>Several co-infections have been described in the context of COVID-19 but only few cases of actinomycosis following SARS-CoV-2 infection have been reported in the literature. We report here the observation of a 48-year-old man, a smoker, who presented, in the aftermath of COVID-19 pneumonia requiring oxygen therapy a pyopneumothorax treated with antibiotic therapy and chest drainage. A few days later, he presented with hemoptysis. The diagnosis of actinomycosis was made based on histopathological data from endoscopic biopsies. The outcome was favorable under adapted and prolonged antibiotic therapy with amoxicillin. Pulmonary actinomycosis, although rare, should be suspected in front of lingering respiratory symptoms and/or atypical radiological findings in the context of a COVID-19.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2411931"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11583601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling disulfidptosis for prognostic modeling and personalized treatment strategies in lung adenocarcinoma. 为肺腺癌的预后建模和个性化治疗策略揭开二硫化钼的神秘面纱。
IF 2.4
Future Science OA Pub Date : 2024-12-01 Epub Date: 2024-11-25 DOI: 10.1080/20565623.2024.2432211
Xiangyu Xu, Bingbing Zhang, Jin Zhang, Hongbiao Ma
{"title":"Unraveling disulfidptosis for prognostic modeling and personalized treatment strategies in lung adenocarcinoma.","authors":"Xiangyu Xu, Bingbing Zhang, Jin Zhang, Hongbiao Ma","doi":"10.1080/20565623.2024.2432211","DOIUrl":"10.1080/20565623.2024.2432211","url":null,"abstract":"<p><strong>Aim: </strong>To construct and identify a prognostic and therapeutic signature based on disulfidptosis-related genes in lung adenocarcinoma.</p><p><strong>Methods: </strong>Bioinformatic analysis was performed to assess the differential expression of disulfidptosis-related genes between cancerous and control samples from The Cancer Genome Atlas-Lung Adenocarcinoma (TCGA-LUAD) database. Survival analysis, immune cell infiltration assessment, and examination of oncogenic pathways were performed to uncover potential clinical implications of disulfidptosis gene expression. Differential gene expression analysis between subtypes facilitated the development of a prognostic model using a combination of genes associated with survival. A nomogram was further created using independent clinical and molecular factors.</p><p><strong>Results: </strong>We identified the significant upregulation of ten disulfidptosis-related genes and delineated two distinct subtypes, C1 and C2. Subtype C2 was associated with prolonged survival. Then, prognostic modeling utilizing six genes (TXNRD1, CPS1, S100P, SCGB3A1, CYP24A1, NAPSA) demonstrated predictive power in both training and validation datasets. The nomogram, incorporating the risk model with clinical features, provided a reliable tool for predicting one-year (AUC 0.77), three-year (AUC 0.75), and five-year (AUC 0.78) survival rates. Additionally, chemotherapy sensitivity analysis highlighted significant resistance in the high-risk group, primarily associated with subtype C1.</p><p><strong>Conclusion: </strong>Our study reveals distinct LUAD subtypes, offers a robust prognostic model, and underscores clinical implications for personalized therapy based on disulfidptosis-related genes expression profiles.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2432211"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11601057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab. 异体单核细胞衍生炎性树突状细胞联合 pembrolizumab 的 I 期研究。
IF 2.4
Future Science OA Pub Date : 2024-12-01 Epub Date: 2024-11-20 DOI: 10.1080/20565623.2024.2426426
Jared Weiss, Douglas Laux, David Bajor, Albert C Lockhart, John Hamm, Jeroen Rovers, Alex Karlsson-Parra
{"title":"Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab.","authors":"Jared Weiss, Douglas Laux, David Bajor, Albert C Lockhart, John Hamm, Jeroen Rovers, Alex Karlsson-Parra","doi":"10.1080/20565623.2024.2426426","DOIUrl":"10.1080/20565623.2024.2426426","url":null,"abstract":"<p><p>PD-1 checkpoint inhibition has revolutionized the care of cancer. A small portion of patients with stage IV cancer achieve durable control. But, early progression is common and dramatic control is achieved for only a minority. We hypothesized that ilixadencel, an allogeneic monocyte-derived dendritic cell product could be injected into tumor to potentiate PD-1 response and thus conducted a phase I study of pembrolizumab plus ilixadencel. Twenty-one patients were accrued. The most common treatment emergent adverse events were fatigue, injection site pain, anemia, weight decreased and hyponatremia, mostly grade 1-2. No dose limiting toxicities were observed and the recommended phase II dose was established at 10 million cells administered twice. Two unconfirmed responses were observed, with no confirmed responses.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2426426"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of TPVB and ESPB for postoperative pain management in thoracic and breast surgeries. 胸外科和乳腺外科术后疼痛治疗中 TPVB 和 ESPB 的比较分析。
IF 2.4
Future Science OA Pub Date : 2024-12-01 Epub Date: 2024-11-22 DOI: 10.1080/20565623.2024.2430852
Moeez Akram, Muhammad Rehan Iftikhar, Quratulain Fatima, Muhammad Ubaida, Hareem Khan, Hadia Mohsin, Muhammad Ibrahim, Muhammad Abdullah Hassan Wattoo, Muhammad Uzair Tahir, Marsad Ali
{"title":"Comparative analysis of TPVB and ESPB for postoperative pain management in thoracic and breast surgeries.","authors":"Moeez Akram, Muhammad Rehan Iftikhar, Quratulain Fatima, Muhammad Ubaida, Hareem Khan, Hadia Mohsin, Muhammad Ibrahim, Muhammad Abdullah Hassan Wattoo, Muhammad Uzair Tahir, Marsad Ali","doi":"10.1080/20565623.2024.2430852","DOIUrl":"10.1080/20565623.2024.2430852","url":null,"abstract":"<p><strong>Objective: </strong>This meta-analysis assesses the efficacy and safety of erector spinae block (ESPB) and paravertebral block (PVB) for managing postoperative pain in thoracic and breast surgeries.</p><p><strong>Design: </strong>Data from 12 randomized controlled trials (RCTs) published between 2019 and 2022 were included, and selected based on stringent criteria.</p><p><strong>Setting: </strong>The RCTs were conducted across various clinical settings, including operating theaters worldwide.</p><p><strong>Patients: </strong>The analysis involved 844 patients undergoing thoracic or breast surgery under regional anesthesia, representing diverse health statuses.</p><p><strong>Interventions: </strong>Patients received either PVB or ESPB, typically guided by ultrasound, for postoperative pain control.</p><p><strong>Main findings: </strong>PVB demonstrated superior pain management during rest and mobility, requiring fewer additional analgesics than ESPB. Incidences of postoperative nausea and vomiting (PONV) and opioid consumption did not differ significantly between the methods. ESPB showed more effective block placement.</p><p><strong>Conclusion: </strong>PVB is preferred for reducing analgesic requirements and managing postoperative pain, especially during rest and activity. ESPB offers advantages in block placement. Surgical type and patient preferences should guide the choice between PVB and ESPB, necessitating further research for optimized clinical application.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2430852"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142692861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biologically active metabolites of Alcaligenes faecalis: diversity, statistical optimization, and future perspectives. 粪阿卡菌的生物活性代谢物：多样性、统计优化和未来展望。
IF 2.4
Future Science OA Pub Date : 2024-12-01 Epub Date: 2024-11-26 DOI: 10.1080/20565623.2024.2430452
Sayed E El-Sayed, Neveen A Abdelaziz, Mohammad Y Alshahrani, Ghadir S El-Housseiny, Khaled M Aboshanab
{"title":"Biologically active metabolites of <i>Alcaligenes faecalis:</i> diversity, statistical optimization, and future perspectives.","authors":"Sayed E El-Sayed, Neveen A Abdelaziz, Mohammad Y Alshahrani, Ghadir S El-Housseiny, Khaled M Aboshanab","doi":"10.1080/20565623.2024.2430452","DOIUrl":"https://doi.org/10.1080/20565623.2024.2430452","url":null,"abstract":"<p><p><i>Alcaligenes faecalis</i> is a Gram-negative, rod-shaped bacterium that is common in the environment and has been reported to have various bioactive metabolites of industrial potential applications, including antifungal, antibacterial, antimycobacterial, antiparasitic, anticancer, antioxidant activities. In this review, we highlighted and discussed the respective metabolites, pointing out their chemical diversities, purification, current challenges, and future directions. <i>A. faecalis</i> has an industrial role in biodegradation, biosurfactants, and different enzyme production. In this review, the up-to-date various Response Surface Methodology methods (RSM) that can be employed for statistical optimization of the bioactive secondary metabolites have been discussed and highlighted, pointing out the optimal use of each method, current challenges, and future directions.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2430452"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142727152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A large gastric inflammatory fibroid polyp revealed by an upper gastrointestinal bleeding: a case report. 上消化道出血揭示的巨大胃炎性纤维瘤息肉：病例报告。
IF 2.4
Future Science OA Pub Date : 2024-12-01 Epub Date: 2024-11-22 DOI: 10.1080/20565623.2024.2431473
Ghada Gharbi, Manel Yakoubi, Asma Ben Mohamed, Moufida Mahmoudi, Mohamed Karim M'Farrej, Mahdi Bouassida, Amal Khsiba, Mouna Medhioub, Emna Chelbi, Lamine Hamzaoui
{"title":"A large gastric inflammatory fibroid polyp revealed by an upper gastrointestinal bleeding: a case report.","authors":"Ghada Gharbi, Manel Yakoubi, Asma Ben Mohamed, Moufida Mahmoudi, Mohamed Karim M'Farrej, Mahdi Bouassida, Amal Khsiba, Mouna Medhioub, Emna Chelbi, Lamine Hamzaoui","doi":"10.1080/20565623.2024.2431473","DOIUrl":"10.1080/20565623.2024.2431473","url":null,"abstract":"<p><p>Inflammatory fibroid polyps (IFPs) are rare submucosal lesions that usually arise in the stomach. It represents 0.1% of all gastric polypoid lesions and are frequently asymptomatic. It's usually revealed by an abdominal pain. Gastrointestinal bleeding can occur when the polyp is ulcerated. We report a case of a 72-year-old female with an IFP of the prepyloric region. The head of the polyp was thirty-five millimeters in diameter. It was revealed by an upper gastrointestinal bleeding and epigastric pain. An endoscopic resection was performed.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2431473"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining symptom and quality of life in polycystic ovarian syndrome: a web-based cross-sectional study. 考察多囊卵巢综合征的症状和生活质量：一项基于网络的横断面研究。
IF 2.4
Future Science OA Pub Date : 2024-12-01 Epub Date: 2024-11-19 DOI: 10.1080/20565623.2024.2430878
Rukaiah Fatma Begum, Chitra Vellapandian, Sumithra Mohan
{"title":"Examining symptom and quality of life in polycystic ovarian syndrome: a web-based cross-sectional study.","authors":"Rukaiah Fatma Begum, Chitra Vellapandian, Sumithra Mohan","doi":"10.1080/20565623.2024.2430878","DOIUrl":"10.1080/20565623.2024.2430878","url":null,"abstract":"<p><strong>Background: </strong>Polycystic Ovarian Syndrome (PCOS) is a reproductive disorder that significantly impacts women's quality of life (QOL). Its unclear etiology, whether genetic or environmental, and the treatments associated with it have been widely studied globally.</p><p><strong>Research design and methods: </strong>This study assessed the QOL of 108 women with PCOS, examining both physical and mental symptoms. Participants completed the Short Form-12 (SF-12) questionnaire through a web-based survey to evaluate their QOL scores.</p><p><strong>Results: </strong>Common symptoms included menstrual irregularity (73.14%), hirsutism (65.7%), acne (62.03%), and obesity (22.22%). Complications such as diabetes mellitus (12.9%), hypertension (2.78%), infertility (1.85%), miscarriages (31.4%), hyperandrogenism (68.51%), and insulin resistance (28.7%) were reported. Patients with infertility had the lowest physical scores (PCS), while those working night shifts had the lowest mental scores (MCS).</p><p><strong>Conclusion: </strong>PCOS significantly affects QOL, with infertility contributing to the lowest physical scores and night shift work correlating with the lowest mental scores. These findings emphasize the need for integrated psychological and physical care, particularly for young working women with PCOS.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2430878"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信